These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 22510481)

  • 1. In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores.
    Sano K; Mitsunaga M; Nakajima T; Choyke PL; Kobayashi H
    Breast Cancer Res; 2012; 14(2):R61. PubMed ID: 22510481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-modality molecular imaging using antibodies labeled with activatable fluorescence and a radionuclide for specific and quantitative targeted cancer detection.
    Ogawa M; Regino CA; Seidel J; Green MV; Xi W; Williams M; Kosaka N; Choyke PL; Kobayashi H
    Bioconjug Chem; 2009 Nov; 20(11):2177-84. PubMed ID: 19919110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green.
    Ogawa M; Kosaka N; Choyke PL; Kobayashi H
    Cancer Res; 2009 Feb; 69(4):1268-72. PubMed ID: 19176373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorophore-quencher based activatable targeted optical probes for detecting in vivo cancer metastases.
    Ogawa M; Kosaka N; Longmire MR; Urano Y; Choyke PL; Kobayashi H
    Mol Pharm; 2009; 6(2):386-95. PubMed ID: 19718793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-specific detection of an optically targeted antibody combined with a quencher-conjugated neutravidin "quencher-chaser": a dual "quench and chase" strategy to improve target to nontarget ratios for molecular imaging of cancer.
    Ogawa M; Kosaka N; Choyke PL; Kobayashi H
    Bioconjug Chem; 2009 Jan; 20(1):147-54. PubMed ID: 19072537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo target-specific activatable near-infrared optical labeling of humanized monoclonal antibodies.
    Ogawa M; Regino CA; Choyke PL; Kobayashi H
    Mol Cancer Ther; 2009 Jan; 8(1):232-9. PubMed ID: 19139133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short PEG-linkers improve the performance of targeted, activatable monoclonal antibody-indocyanine green optical imaging probes.
    Sano K; Nakajima T; Miyazaki K; Ohuchi Y; Ikegami T; Choyke PL; Kobayashi H
    Bioconjug Chem; 2013 May; 24(5):811-6. PubMed ID: 23600922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo molecular imaging to diagnose and subtype tumors through receptor-targeted optically labeled monoclonal antibodies.
    Koyama Y; Barrett T; Hama Y; Ravizzini G; Choyke PL; Kobayashi H
    Neoplasia; 2007 Dec; 9(12):1021-9. PubMed ID: 18084609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.
    Sampath L; Kwon S; Ke S; Wang W; Schiff R; Mawad ME; Sevick-Muraca EM
    J Nucl Med; 2007 Sep; 48(9):1501-10. PubMed ID: 17785729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing breast cancer xenograft epidermal growth factor receptor expression by using near-infrared optical imaging.
    Wang K; Wang K; Li W; Huang T; Li R; Wang D; Shen B; Chen X
    Acta Radiol; 2009 Dec; 50(10):1095-103. PubMed ID: 19922304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo diagnosis of epidermal growth factor receptor expression using molecular imaging with a cocktail of optically labeled monoclonal antibodies.
    Barrett T; Koyama Y; Hama Y; Ravizzini G; Shin IS; Jang BS; Paik CH; Urano Y; Choyke PL; Kobayashi H
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6639-48. PubMed ID: 17982120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activatable fluorescence detection of epidermal growth factor receptor positive mediastinal lymph nodes in murine lung cancer model.
    Zhang X; Nakajima T; Kim M; Yamaguchi A; Lamid-Ochir O; Nguyen-Thu H; Bhattarai A; Hanaoka H; Tsushima Y
    PLoS One; 2018; 13(6):e0198224. PubMed ID: 29856819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo photoacoustic imaging of cancer using indocyanine green-labeled monoclonal antibody targeting the epidermal growth factor receptor.
    Sano K; Ohashi M; Kanazaki K; Ding N; Deguchi J; Kanada Y; Ono M; Saji H
    Biochem Biophys Res Commun; 2015 Aug; 464(3):820-5. PubMed ID: 26168727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-Labeled Near-Infrared/(99m)Tc Imaging Probes Using PAMAM-Coated Silica Nanoparticles for the Imaging of HER2-Expressing Cancer Cells.
    Yamaguchi H; Tsuchimochi M; Hayama K; Kawase T; Tsubokawa N
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies.
    Terwisscha van Scheltinga AG; van Dam GM; Nagengast WB; Ntziachristos V; Hollema H; Herek JL; Schröder CP; Kosterink JG; Lub-de Hoog MN; de Vries EG
    J Nucl Med; 2011 Nov; 52(11):1778-85. PubMed ID: 21990576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micelle-based activatable probe for in vivo near-infrared optical imaging of cancer biomolecules.
    Shimizu Y; Temma T; Hara I; Makino A; Yamahara R; Ozeki E; Ono M; Saji H
    Nanomedicine; 2014 Jan; 10(1):187-95. PubMed ID: 23811292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An ERBB1-3 Neutralizing Antibody Mixture With High Activity Against Drug-Resistant HER2+ Breast Cancers With ERBB Ligand Overexpression.
    Schwarz LJ; Hutchinson KE; Rexer BN; Estrada MV; Gonzalez Ericsson PI; Sanders ME; Dugger TC; Formisano L; Guerrero-Zotano A; Red-Brewer M; Young CD; Lantto J; Pedersen MW; Kragh M; Horak ID; Arteaga CL
    J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059433
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.